Clinical Trial

Cobas® Lumira Collection of Venous and Capillary Blood Samples for the Research, Optimization and Calibration of New Diagnostic Devices

Study acronym: EVOLVE
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study is a blood sample collection study, collecting venous and capillary blood samples from adult patients in the UK, with a range of health conditions. The purpose of this study is to collect blood samples to help develop, improve, and fine-tune new and existing diagnostic tests for the cobas® lumira instrument. This instrument is a diagnostic medical device with single-use test strips, that allows diagnostic testing right at the patient's side. The aim is to improve doctors' ability to monitor health conditions more quickly and easily. Approximately 30,000 patients are expected to participate in this study, across multiple UK sites.
Trial Details
NCT Number NCT07378514
Lead Sponsor LumiraDx UK Limited
Conditions Blood Clots, Infection and Inflammatory Reaction, Heart Disease, Kidney Disease, Vitamin K Antagonist, Diabetes, High Cholesterol, Liver Disease
Enrollment 30,000 participants
Start Date 2026-04
Primary Completion 2031-04 (estimated)
Study Completion 2031-07 (estimated)
Updated on ClinicalTrials.gov 2026-01-30